Home » Authors » Anette Breindl

Articles by Anette Breindl

Compound Blocks Thrombosis But Doesn't Increase Bleeding

June 20, 2005

By Anette Breindl

Medium Is Message In New Genome Variation Mapping

June 13, 2005

By Anette Breindl

Medium Is Message In New Genome Variation Mapping

June 13, 2005

By Anette Breindl

First Ebola/Marburg Vaccine Successfully Jumps Species

June 10, 2005

By Anette Breindl

First Ebola/Marburg Vaccine Successfully Jumps Species

June 10, 2005

By Anette Breindl

Cell-Cycle Inhibitors Might Be Able To Treat Brain Injury

June 8, 2005

By Anette Breindl

Cell-Cycle Inhibitors Might Be Able To Treat Brain Injury

June 8, 2005

By Anette Breindl

After Clinical Setback, Glucose Synthesis Inhibitor Moves On

June 6, 2005

By Anette Breindl

After Clinical Setback, Glucose Synthesis Inhibitor Moves On

June 6, 2005

By Anette Breindl

New Anti-Angiogenesis Theory: How To Give Tumors A Stroke

June 3, 2005

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...